IN BRIEF: Tern's FundamentalVR Secures GBP400,000 Contract Win

Wed, 02nd Dec 2020 17:39

Tern PLC - internet of things-focused investor - Portfolio company FVRVS Ltd wins GBP400,000 contract with existing client, a "leading pharmaceutical" firm, to support training and adoption of Ocular Gene Therapy product. "The contract covers ongoing repeat licences and support to continue the global rollout of the client's virtual reality training solution, built by FundamentalVR," Tern says.

Current stock price: 6.88 pence

Year-to-date change: down 21%

By Eric Cunha; ericcunha@alliancenews.com

Related Shares

More News

12 Apr 2024 14:16

Tern raises £0.42m to invest in Wyld Networks

(Sharecast News) - Specialist internet-of-things technology investor Tern announced on Friday that it hs raised £0.42m before expenses, to invest...

12 Apr 2024 10:04

AIM WINNERS & LOSERS: Bens Creek falls as it lays off workers

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.

12 Apr 2024 09:43

IN BRIEF: Tern down after raising GBP420,000 via discounted placing

Tern PLC - London-based 'internet of things' technology investor - Raises GBP420,000 via placing 17.5 million shares at 2.4 pence each. The placing pr...

9 Apr 2024 10:38

Tern investee reports "substantial interest" from industry leaders

(Alliance News) - Tern PLC on Tuesday announced that one of its investee company's had a strong start to the year.

9 Apr 2024 10:32

Tern's Talking Medicines makes 'strong start' to FY24

(Sharecast News) - Internet of Things investor Tern said on Tuesday that Talking Medicines, in which it currently holds a 23.8% equity share, has made...